SLC13A5 and type 2 diabetes mellitus: The alteration of the SLC13A5 expression and function in these tissues is closely associated with obesity, type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), inflammation, cancer, and neurological disorders.